ETF Holdings Breakdown of RYTM

News associated with RYTM

Avior Wealth Management LLC Acquires Shares of 4,589 Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Avior Wealth Management LLC acquired a new stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) in the 1st quarter, HoldingsChannel.com reports. The firm acquired 4,589 shares of the company’s stock, valued at approximately $243,000. Several other institutional investors and hedge funds have also bought and sold shares of the business. Assenagon Asset […] - 2025-06-24 07:52:55

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Consensus Recommendation of “Buy” from Analysts

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) has received a consensus recommendation of “Buy” from the thirteen analysts that are presently covering the firm, MarketBeat.com reports. Thirteen investment analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have updated their coverage on the stock in […] - 2025-06-12 07:56:54

Universal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 76,084 Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm acquired 76,084 shares of the company’s stock, valued at approximately $4,259,000. A number of other hedge funds and other institutional investors have also added to or reduced their […] - 2025-06-02 08:36:58

Nuveen Asset Management LLC Sells 972 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Nuveen Asset Management LLC decreased its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 0.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 146,903 shares of the company’s stock after selling 972 shares during […] - 2025-05-29 08:36:56

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 33,156 shares of the company’s stock after buying an additional 654 shares during […] - 2025-05-23 08:32:53

Analysts Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) PT at $75.38

Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus recommendation of “Buy” from the thirteen brokerages that are currently covering the company, MarketBeat Ratings reports. Thirteen analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage on […] - 2025-05-23 07:30:49

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Purchased by BNP Paribas Financial Markets

BNP Paribas Financial Markets boosted its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 491.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 85,249 shares of the company’s stock after purchasing an additional 70,824 shares during the period. BNP […] - 2025-05-14 09:42:59

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Sold by Comerica Bank

Comerica Bank lowered its stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 2.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 17,113 shares of the company’s stock after selling 447 shares during the period. Comerica Bank’s holdings in Rhythm Pharmaceuticals were worth $958,000 as of its most recent filing with the […] - 2025-05-13 09:00:54

Stifel Financial Corp Has $1.09 Million Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Stifel Financial Corp decreased its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 1.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,516 shares of the company’s stock after selling 326 shares during the quarter. Stifel Financial Corp’s holdings in […] - 2025-05-09 08:27:01

First Trust Advisors LP Has $6.63 Million Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

First Trust Advisors LP grew its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 67.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 118,337 shares of the company’s stock after buying an additional 47,575 shares during the period. First Trust Advisors LP owned 0.19% of […] - 2025-04-30 09:01:00

Legal & General Group Plc Reduces Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Legal & General Group Plc decreased its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 7.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,803 shares of the company’s stock after selling 4,244 shares during the period. Legal & General […] - 2025-04-24 08:07:03

Invesco Ltd. Has $16.95 Million Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Invesco Ltd. grew its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 14.5% in the 4th quarter, Holdings Channel reports. The institutional investor owned 302,846 shares of the company’s stock after purchasing an additional 38,429 shares during the period. Invesco Ltd.’s holdings in Rhythm Pharmaceuticals were worth $16,953,000 at the end of the […] - 2025-04-21 07:44:46

Trexquant Investment LP Takes $437,000 Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Trexquant Investment LP bought a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 7,798 shares of the company’s stock, valued at approximately $437,000. A number of other large investors have also recently added to or reduced their stakes in RYTM. SRS Capital Advisors […] - 2025-04-13 08:31:02

Rhythm Pharmaceuticals (NASDAQ:RYTM) Raised to Buy at Bank of America

Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) was upgraded by analysts at Bank of America from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Monday, MarketBeat.com reports. The firm presently has a $63.00 price objective on the stock. Bank of America‘s price objective points to a […] - 2025-04-09 05:52:50

Norges Bank Acquires New Shares in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Norges Bank bought a new position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 205,649 shares of the company’s stock, valued at approximately $11,512,000. Norges Bank owned approximately 0.33% […] - 2025-04-08 07:48:51

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $91.00

Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its price target upped by Wells Fargo & Company from $80.00 to $91.00 in a research note published on Monday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other research firms have also recently issued reports on RYTM. Morgan Stanley restated […] - 2025-04-08 05:52:50

Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Gap Up After Analyst Upgrade

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s stock price gapped up before the market opened on Monday after Wells Fargo & Company raised their price target on the stock from $80.00 to $91.00. The stock had previously closed at $46.95, but opened at $48.33. Wells Fargo & Company currently has an overweight rating on […] - 2025-04-08 05:12:52

Corebridge Financial Inc. Has $1.52 Million Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Corebridge Financial Inc. decreased its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 7.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,220 shares of the company’s stock after selling 2,054 shares during the period. […] - 2025-04-03 08:49:02

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Consensus Rating of “Moderate Buy” from Analysts

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average 1-year price […] - 2025-04-03 07:54:49

Cibc World Markets Corp Purchases New Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Cibc World Markets Corp acquired a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 5,123 shares of the company’s stock, valued at approximately $287,000. Several other institutional investors also recently modified their holdings of […] - 2025-03-26 08:08:48

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $66.00 at Needham & Company LLC

Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price increased by Needham & Company LLC from $64.00 to $66.00 in a research note released on Tuesday, Marketbeat reports. Needham & Company LLC currently has a buy rating on the stock. RYTM has been the topic of several other reports. The Goldman Sachs Group raised […] - 2025-03-19 06:47:04

Analysts Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Target Price at $68.27

Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average […] - 2025-03-07 06:25:02

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $70.00 at HC Wainwright

Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) had its price objective hoisted by investment analysts at HC Wainwright from $69.00 to $70.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 31.53% from the company’s previous close. […] - 2025-03-05 07:04:55

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB lessened its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 11.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 17,021 shares of the company’s stock after selling 2,300 shares during the period. Handelsbanken Fonder AB’s holdings in Rhythm Pharmaceuticals were worth $953,000 at the end of […] - 2025-02-28 09:25:12

35,004 Shares in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Purchased by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D acquired a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) in the 4th quarter, Holdings Channel reports. The institutional investor acquired 35,004 shares of the company’s stock, valued at approximately $1,960,000. Other institutional investors have also recently bought and sold shares of the company. Loomis […] - 2025-02-25 08:34:48

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1-year […] - 2025-02-14 08:22:55

abrdn plc Has $4.51 Million Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

abrdn plc trimmed its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 28.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,517 shares of the company’s stock after selling 32,287 shares during the period. abrdn plc owned 0.13% […] - 2025-02-10 18:42:59

KBC Group NV Acquires 988 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

KBC Group NV increased its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 78.2% during the 4th quarter, Holdings Channel reports. The firm owned 2,251 shares of the company’s stock after acquiring an additional 988 shares during the quarter. KBC Group NV’s holdings in Rhythm Pharmaceuticals were worth $126,000 at the end of […] - 2025-02-08 08:36:51

Chicago Partners Investment Group LLC Reduces Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Chicago Partners Investment Group LLC cut its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 21.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,696 shares of the company’s stock after selling 1,029 shares during the quarter. Chicago Partners Investment […] - 2025-02-06 08:36:50

R Squared Ltd Acquires Shares of 780 Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

R Squared Ltd acquired a new stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 780 shares of the company’s stock, valued at approximately $44,000. Other institutional investors and hedge funds have also recently modified their […] - 2025-02-03 08:46:52

RYTM institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	30,979	USD 1,903,505
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	4,715	USD 289,713
2025-06-26	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	71,865	USD 4,415,745
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	31,749	USD 1,950,817
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	31,749	USD 1,950,817
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	167	USD 10,261
Total =		171,224	USD 10,520,858

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer